F175-1192 Screening compound: 1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)piperidine-4-carboxamide

F175-1192 Screening compound: 1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)piperidine-4-carboxamide
F175-1192 Screening compound: 1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F175-1192
1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F175-1192

Molecular Formula

C25H27N5O5S2 (C25 H27 N5 O5 S2)

Compound Name

1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]-N-(6-methoxy-1,3-benzothiazol-2-yl)piperidine-4-carboxamide

IUPAC name

1-[5-(5-ethyl-124-oxadiazol-3-yl)-2-methylbenzenesulfonyl]-N-(6-methoxy-13-benzothiazol-2-yl)piperidine-4-carboxamide

SMILES

CCc1nc(-c2cc(S(N(CC3)CCC3C(Nc3nc(ccc(OC)c4)c4s3)=O)(=O)=O)c(C)cc2)no1

InChI

InChI=1S/C25H27N5O5S2/c1-4-22-27-23(29-35-22)17-6-5-15(2)21(13-17)37(32,33)30-11-9-16(10-12-30)24(31)28-25-26-19-8-7-18(34-3)14-20(19)36-25/h5-8,13-14,16H,4,9-12H2,1-3H3,(H,26,28,31)

InChI Key

QPXXLVTVHSRENX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27106857

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

541.65

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

5.253

Distribution Coefficient, logD

5.252

Water Solubility, LogSw

-5.01

Polar Surface Area

103.689

Acid Dissociation Constant (pKa)

10.99

Base Dissociation Constant (pKb)

1.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

F175-1192 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with F175-1192 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F175-1192?
Check Price and Availability of F175-1192, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F175-1192 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F175-1192
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F175-1192
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F175-1192 available by request